论文信息 - Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations - 字舞流文

Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations

K. Ishii | Y. Sunada | R. Takahashi | R. Uozumi | S. Morita | M. Ikeda | Takashi Suehiro | K. Shigenobu | H. Inoue | Y. Izumi | K. Fujita | T. Kondo | H. Tomimoto | O. Uchikawa | H. Tada | H. Banno | S. Kawakatsu | Kohji Mori | A. Shindo | K. Kanemaru | Yoko Amino | A. Kinoshita | H. Ishikawa | T. Maki | Yosuke Taruno | A. Nakakura | K. Yasuda | Y. Kutoku | Kayoko Endo | T. Okunomiya | Shunji Shiota | Toshifumi Watanabe